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Abstract
Background and Purpose: The appearance of the renal papillae in patients with nephrolithiasis can be quite
variable and can range from entirely healthy to markedly diseased. The implications of such findings remain
unknown. One potential reason is the lack of a standardized system to describe such features. We propose a
novel grading scale to describe papillary appearance at the time of renal endoscopy.
Methods: Comprehensive endoscopic renal assessment and mapping were performed on more than 300 patients
with nephrolithiasis. Recurring abnormal papillary characteristics were identified and quantified based on
degree of severity.
Results: Four unique papillary features were chosen for inclusion in the PPLA scoring system— ductal
Plugging, Pitting, Loss of contour, and Amount of Randall’s plaque. Unique scores are calculated for individual
papillae based on reference examples.
Conclusions: The description and study of renal papillary appearance in stone formers have considerable
potential as both a clinical and research tool; however, a standardized grading system is necessary before using
it for these purposes.
Introduction
Technologic advancements in the field of en-dourology have revolutionized the ability to treat ne-
phrolithiasis. Whereas surgeons once had to remove stones
from the ureter using a combination of blind basketing and
fluoroscopy, it is now possible not only to visualize the en-
tirety of the urinary tract but also to do so in high definition.
Much of the clinical interest in modern scope technology has
focused on enhanced optics for stone visualization and re-
moval. The significance of improved visualization of the
kidney and collecting system themselves, however, is often
overlooked. Through correlation with stone analysis and
papillary biopsy, our group has previously demonstrated that
it is possible to distinguish specific stone forming phenotypes
by endoscopic patterns of papillary appearance alone.1–4
Coincident with this finding is a separate important con-
cept that certain types of stone forming pathologies appear to
correspond to a greater degree of renal papillary injury. For
example, patients with a history of brushite stones, renal tu-
bular acidosis, and primary hyperparathyroidism all have
diffuse evidence of abnormal papillary morphology that
corresponds to tissue damage seen on biopsy specimens.1,5–7
Furthermore, this papillary injury is potentially measurable
and distinct from one stone forming pathology to the next as
demonstrated by the fact that patients with primarily calcium
phosphate stones have greater degrees of visible papillary
injury (flattening and erosion) as well as ductal plugs com-
pared with idiopathic calcium stone formers.8
Despite these findings, there is a paucity of medical liter-
ature correlating the degree of visible renal injury to clinical
outcomes. One possible reason that this concept has not
matured is the inherent complexity in describing the multi-
tude of possible variations in papillary appearance in a sim-
plified yet meaningful fashion.
We believe that a standardized approach toward describing
papillary appearance at the time of endourologic assessment
potentially has profound implications in the management of
stone disease. This is especially true considering that flexible
ureteroscopy is one of the most commonly performed uro-
logic surgical procedures and is growing at a rapid rate.9 As
such, the potential diffusion of such a system is considerable
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and has tremendous potential for use as a clinical and re-
search tool. We describe a novel grading system designed to
standardize and simplify the description of renal papillary
appearance in stone formers at the time of endoscopy.
Methods
Since 1999, 342 patients have been prospectively enrolled
and given consent to be part of an NIH funded project (PO1
DK56788) studying the pathogenesis of stone formation at a
single institution (Methodist Hospital, Indiana University
Health). A standardized protocol for digital video mapping of
the intrarenal collecting system has been described previ-
ously.10 All procedures, whether percutaneous or uretero-
scopic, were initially performed using fiberoptic scopes. Over
the past several years, there has been a shift to digital en-
doscopy because such equipment has become more readily
available and offers superior optics.
We have used these observations to describe several
mechanisms of human kidney stone formation11 and have
characterized the phenotypes as they apply to stone formation
in nine different disease states as well as those with no history
of stones.12 The two predominant mechanisms of stone for-
mation (growth onRandall’s plaque and Bellini duct plugging)
manifest themselves with uniquely different characteristics.
Randall’s plaque, evident as white suburothelial deposits, does
not cause cellular injury.13 Bellini duct plugging on the other
hand, evident as focal yellow mineral deposits and/or dilated
ducts where the mineral deposits once existed, does cause
progressive damage to the nephron.14 This progressive injury
can eventually lead to other gross changes in the papilla in-
cluding pitting (a crater-like erosion of the papillary tip) or loss
of contour (a diffuse flattening of the papilla in its entirety).6
A grading system was subsequently devised based on the
collective knowledge and experience of the primary research
team to better characterize the presence and degree of ab-
normal papillary appearance in patients with nephrolithiasis
(Table 1). It should be noted that persons with medullary
sponge kidney are a unique population of stone formers and
while they, too, are likely to demonstrate many of the ab-
normal features described by this scale, they represent a un-
ique pathophysiology very unlike other common stone-
forming conditions and should be considered separately.15
The grading system is applied uniquely to each papilla so
that each one receives its own score. Scoring should not be
performed until all stones overlying or attached to the pap-
illary surface are removed. Each papilla is given a score in
four separate domains: Plugging, pitting, loss of contour, and
amount of Randall’s plaque (PPLA). Plugging, pitting, and loss
of contour are graded as 0, 1, or 2. Amount of Randall’s plaque
is graded as a, b, or c. A final score is calculated by adding the
plugging, pitting, and loss of contour scores together and des-
ignating the grade of Randall’s plaque separately.
For example, a perfectly healthy papilla would receive the
lowest possible score of 0(a). The most diseased papilla
would receive the highest possible score of 6(c). After
identifying and assigning scores to all papillae within the
renal unit, a mean PPLA score can be calculated by dividing
the sum of the papillae scores by the number of papillae
examined. In addition, the lowest and highest papillary
scores are each identified to denote the range of pathology
encountered.
The grading system is intended for use with a digital in-
strument because such scopes offer optimal visualization,
although fiberoptic scopes do have the potential of capturing
sufficient detail regarding the appearance of the papilla under
ideal circumstances. Furthermore, it is intended for use only
when the papilla can be fully visualized and should not be
applied unless a comprehensive view of the papilla can be
obtained. Finally, in instances of compound papillae, the
entire papillary unit is considered a single papilla unless there
is a discrete separation and minimal tissue bridging between
the two structures.
Results
Randall’s plaque
This plaque is characteristically white and can be visual-
ized as irregular lesions most common near the tip of the
papilla but with potential to appear anywhere on its surface.
While frequently encountered in patients with nephro-
lithiasis, it has not been shown to cause injury at the level of
the nephron13 and as such is designated with an alphabetic
rather than numeric score. (Fig. 1A–C)
Plugging
Bellini duct plugging can manifest in one of two ways. One
is as yellow intraductal mineral deposits visualized just under
the urothelial surface or protruding from the mouth of a dilated
duct itself. The other manifestation is as an empty dilated duct
where a plug once existed. A normal Bellini duct is only 300 to
600 micrometers on average, but a dilated, diseased duct can
distend to many times that diameter (Fig. 2A–D).
Table 1. Scale for Abnormal Papillary Appearance
Score 0 1 2
Plugging 0 yellow plaque
deposits/dilated
ducts
£5 yellow plaque
deposits/dilated ducts
>5 yellow plaque
deposits/dilated ducts
Pitting None £25% papillary surface
involved
‡25% papillary surface
involved
Loss of contour None Depressed Completely flattened
Grade a b c
Amount of Randall’s plaque Mild Moderate Severe
Final PPLA score Sum (letter)
PPA = plugging, pitting, loss of contour, amount of Randall’s plaque.
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FIG. 1. (A) Healthy papilla with mild amount of Randall’s plaque (black arrowheads) (Plugging= 0, Pitting= 0, Loss of
Contour= 0, Randall’s plaque= a [PPLA 0a]). (B) Healthy papilla with moderate amount of Randall’s plaque (black arrow-
heads) (Plugging= 0, Pitting= 0, Loss of Contour= 0, Randall’s plaque= b [PPLA 0b]). (C) Healthy papilla with extensive
amount of Randall’s plaque (black arrowheads) (Plugging= 0, Pitting= 0, Loss of Contour= 0, Randall’s plaque= c [PPLA 0c]).
FIG. 2. (A) This compound papilla demonstrates numerous deposits of yellow plaque, cumulatively more than 5 (black
arrows). Dilated ducts with protruding yellow mineral deposits are designated with the asterisk. There is no evidence of
pitting or loss of contour. A minute amount of Randall’s plaque can be visualized by the arrowheads in the lower right
corner (Plugging = 2, Pitting = 0, Loss of Contour = 0, Randall’s plaque = a [PPLA 2a]). (B) This papilla also demonstrates
plugging as evidenced by both yellow plaque (black arrows) and dilated ducts, some of which contain protruding yellow
mineral deposits (asterisk). There is no evidence of pitting and an intermediate loss of contour. A minimal amount of
Randall’s plaque can be seen as designated by the black arrowheads (Plugging= 2, Pitting = 0, Loss of Contour = 1,
Randall’s plaque = a (PPLA 3a). (C) This papilla has many yellow plaque deposits (black arrows). One large dilated duct
can be seen in the center of the papilla (asterisk) that is magnified in Figure 2D. There is no pitting, intermediate loss of
contour, and minimal Randall’s plaque (Plugging= 2, Pitting = 0, Loss of Contour = 1, Randall’s plaque= a [PPLA 3a]). (D)
This image is the magnification of the central region of Figure 2C. Yellow plaque deposits are again designated with black
arrows. The prominent dilated duct of Bellini is designated by the asterisk within it.
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Pitting
Pitting describes crater-like, focal erosion in the surface of
the papilla. These changes are most frequently seen at the
papillary tip and are likely a manifestation of progressive renal
injury and damaged nephrons (Fig. 3A,B). We suspect that
pitting may arise either by one of two mechanisms. One is via
progressive ductal plugging that leads to focal tubular atrophy
and nephron loss.6,8 The other is bymechanical disruption and
spontaneous passage of an attached stone whereby the stone
pulls off part of the urothelium and underlying tubules. This
has been demonstrated to occur naturally based on the finding
of renal tubules adherent to spontaneously passed stones when
imaged using scanning electron microscopy.16
Loss of contour
Loss of papillary contour is an advanced stage of papillary
injury believed to be indicative of global loss of papillary
volume (Fig. 4 A,B). A normal papilla should have the shape
of a mountain peak or tall hill (grade 0) (Fig. 1). As loss of
contour occurs, the peak becomes flattened into a more
plateau like architecture (grade 1) (Fig. 4A) and ultimately
demonstrates complete flattening relative to the surrounding
tissue similar to a plain (grade 2) (Fig. 4B). Another po-
tential etiology for loss of contour is obstruction, especially
in instances of chronic hydronephrosis. As such, we do not
recommend applying the scoring system to these patients at
this time.
FIG. 3. (A) This papilla has pitting focused at the periphery of the papillary tip (black circle). Less than 25% of the
papillary surface is affected. A single yellow plaque deposit is marked by a black arrow. The papilla has no loss of contour
and a severe amount of Randall’s plaque (black arrowheads) (Plugging = 1, Pitting = 1, Loss of Contour = 0, Randall’s
plaque = c [PPLA 2c]). (B) This compound papilla demonstrates pitting with more than 25% of the papillary surface affected
(black circle). There is no evidence of plugging or loss of contour. Moderate Randall’s plaque is seen (Plugging= 0,
Pitting = 2, Loss of Contour = 0, Randall’s plaque = b [PPLA 2b]).
FIG. 4. (A) This papilla has a number of abnormal findings including numerous deposits of yellow plaque (black arrows),
<25% pitting (black circle), a moderate loss of contour, and several small foci of Randall’s plaque (black arrowheads)
(Plugging = 2, Pitting = 1, Loss of Contour = 1, Randall’s plaque = a [PPLA 4a]). (B) This papilla has several foci of yellow
plaque (black arrows) and dilated ducts (asterisk), moderate pitting (black circle), and complete loss of contour. There is
minimal Randall’s plaque (arrowhead) (Plugging= 2, Pitting = 1, Loss of Contour = 2, Randall’s plaque = a [PPLA 5a]).
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Discussion
Review of endoscopic videos has made a tremendous
contribution to our understanding of papillary disease and
injury. There is currently no system to our knowledge that
characterizes papillary disease in a measurable and repro-
ducible manner, however. We have created a papillary
grading system that quantifies the degree of visible papillary
injury based on recurring abnormal features commonly en-
countered in patients with stone disease. These features are
particularly important to identify and characterize given their
known association with cellular injury, fibrosis, and damage
to the papilla and kidney.11,13
We have also chosen to include a subscore within our
grading scale delineating the relative amount of surface
Randall’s plaque. Randall’s plaque is the most proven path-
way for stone formation, serving as an anchor for calcium
oxalate stone overgrowth in idiopathic calcium stone for-
mers.13,17,18 To date, it has not been shown to be a direct
cause of renal injury; however, this does not mean that it
should be considered a normal or inert finding.
Randall’s plaque has been demonstrated to be far more
common in patients with a history of stone disease compared
with those without.19 Furthermore, the percent coverage of
the papilla by Randall’s plaque has been shown to correspond
directly to an increasing number of stones.20 It is possible that
as our collective knowledge regarding mechanisms of stone
pathogenesis continues to evolve, our understanding re-
garding the role and importance of Randall’s plaque may
grow as well. There is also a possibility that the presence and
degree of Randall’s plaque may have previously overlooked
phenotypic associations with other papillary findings in cer-
tain types of stone-forming diseases. As such, we believe that
it is an important component of our proposed scale.
Establishing a standardized system for grading papillary
injury is necessary from both a clinical and academic per-
spective. On a clinical level, it would allow physicians who
care for patients with nephrolithiasis to more accurately and
consistently document intraoperative findings and follow
changes in their patients over time. Furthermore, it has the
potential to create a reference standard of normal and ab-
normal through which it might help distinguish patients with
more pressing needs of metabolic evaluations, medical ther-
apy, and frequent surveillance imaging.
As a research tool, a grading system has the potential to
allow surgeons to better correlate endoscopic findings to
pathologic findings and clinical outcomes such as stone
analysis, associated metabolic diseases, risk of progressive
renal injury, and stone recurrence. It also has the potential to
simplify the process of endoscopic characterization of the
kidney. Currently, there are only two ongoing institutional
efforts to endoscopically characterize stone formers.10,13,21
One likely reason for this relative lack of interest is the in-
tensely demanding nature of the characterization process
whereby video editing and image processing is used to pre-
cisely calculate surface plaque percentages after the proce-
dure is completed. With the proposed grading scale,
characterization can be performed much more efficiently,
even at the same time as stone removal rather than necessi-
tating video review at a later time.
Currently, the majority of research in the field of ne-
phrolithiasis focuses on the relationship between radio-
graphic findings and clinical outcomes. Radiologic imaging,
while useful, does not provide nearly the same degree of
detail as renal endoscopy, however. It cannot reliably predict
the precise location of stones within the collecting system,
whether they are attached to plaque, located within a duct, or
free floating. Most notably, radiographic imaging is nearly
entirely unable to deliver detailed information regarding the
status or health of the papillae, the predominant point of
origin of the majority of stones.
It is our belief that radiographic imaging in stone formers is
best used in adjunct to renal endoscopy because each meth-
odology offers unique information. We are hopeful that in
creating a standardized method of describing papillary ap-
pearance, we help shift the perception of renal endoscopy as
solely a tool for treatment to one of diagnosis as well.
There are several important future aims of our currently
proposed grading scale. Next, we must validate the instru-
ment among the wider urologic community, ensuring that
accurate grading is widely reproducible. Data from our own
center suggest that this is feasible, at least among those most
familiar with the system. Among 90 papillae independently
graded in a blinded fashion by the senior and junior surgeon
involved in the creation of this system (JEL and MSB),
correlation of pathology was high (Table 2) with a minimum
72% agreement for each of the four measured domains. The
papillary injury sum was also able to be reliably scored with
agreement within one degree in 86% of cases. Further vali-
dation efforts among a larger number of graders familiar with
renal endoscopy are currently ongoing.
In addition, we hope to study potential associations be-
tween papillary scoring and clinical outcomes. To date, the
foundational studies establishing that abnormal papillary
appearance on endoscopy correlates to cellular injury on a
microscopic level have been performed based on biopsy
specimens from small cohorts of patients representing pure
phenotypes of stone-forming diseases.6 Given the small
sample sizes in these cohorts, however, determining the
overall clinical significance of these findings has been a
challenge. The establishment of a grading scale would be a
great asset in this regard, because it would enable researchers
to study links between papillary pathology and other impor-
tant clinical outcomes such as stone analysis, renal function,
stone recurrence, and links tometabolic pathophysiologies on
a much larger scale.
Table 2. Comparison of Grades in 90 Papillae Based
on Senior Level Versus Junior Level Surgeon
PPLA
Assigned
same
grade
1 degree
difference in
assigned grade
>1 degree
difference in
assigned grade
Plugging 80% 20% N/A
Pitting 76% 21% 2%
Loss of
contour
72% 28% N/A
Amount of
Randall’s
plaque
84% 16% N/A
Sum 58% 28% 13%
PPLA = plugging, pitting, loss of contour, amount of Randall’s
plaque.
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Finally, we must determine whether accurate and repro-
ducible scoring is dependent on the type of endoscope used.
Digital endoscopes are able to provide a more detailed image
during endoscopy and are our preferred instrument for such
procedures; however, we believe that the information nec-
essary for papillary grading is readily apparent using a fi-
beroptic scope as well. Studies will be needed to determine
whether the type of instrument used significantly affects the
ability to assign a proper grade, although this may become a
moot point as digital technology supplants older fiberoptic
instruments over time.
Conclusions
We have established a papillary grading system that
characterizes abnormal papillary appearance and visible in-
jury. Ultimately, we are hopeful that such a system proves
useful as a powerful clinical and research tool. Furthermore,
we are hopeful that it might help raise awareness regarding
the importance of examining the papillae at the time of en-
doscopy, because such observations can have profound im-
plications in providing optimal patient care.
Acknowledgments
The authors appreciate the assistance of Philip Blomgren
for assistance in the preparation of digital images.
Research was funded in part by NIH grant #P01 DK56788.
Author Disclosure Statement
Dr. Lingeman is a consultant/advisor, investor, meeting
participate/lecturer, scientific study trial participant for Boston
Scientific Corp.; owner, medical director for Beck Analytical;
Dr. Coe is a consultant for Labcorp; Dr. Worcester is a con-
sultant for Litholink. For the remaining authors, no competing
financial interests exist.’
References
1. Evan AP, Lingeman J, Coe F, et al. Renal histopathology of
stone-forming patients with distal renal tubular acidosis.
Kidney Int 2007;71:795–801.
2. Matlaga BR, Williams JC Jr, Kim SC, et al. Endoscopic
evidence of calculus attachment to Randall’s plaque. J Urol
2006;175:1720–1724.
3. Miller NL, Williams JC Jr, Evan AP, et al. In idiopathic
calcium oxalate stone-formers, unattached stones show
evidence of having originated as attached stones on Ran-
dalls plaque. BJU Int 2010;105:242–245.
4. Coe FL, Evan AP, Worcester EM, Lingeman JE. Three
pathways for human kidney stone formation. Urol Res
2010;38:147–160.
5. Evan AE, Lingeman JE, Coe FL, et al. Histopathology and
surgical anatomy of patients with primary hyperparathy-
roidism and calcium phosphate stones. Kidney Int
2008;74:223–229.
6. Evan AP, Lingeman JE, Coe FL, et al. Crystal-associated
nephropathy in patients with brushite nephrolithiasis. Kid-
ney Int 2005;67:576–591.
7. Matlaga BR, Coe FL, Evan AP, Lingeman JE. The role of
Randall’s plaques in the pathogenesis of calcium stones.
J Urol 2007;177:31–38.
8. Evan AP, Lingeman JE, Worcester EM, et al. Contrasting
histopathology and crystal deposits in kidneys of idiopathic
stone formers who produce hydroxy apatite, brushite, or
calcium oxalate stones. Anat Rec (Hoboken) 2014;297:
731–748.
9. Oberlin DT, Flum AS. Bachrach L, et al. Contemporary
surgical trends in the management of upper tract calculi. J
Urol 2015;193:880–884.
10. Kuo RL, Lingeman JE, Evan AP, et al. Endoscopic renal
papillary biopsies: A tissue retrieval technique for histo-
logical studies in patients with nephrolithiasis. J Urol
2003;170:2186–2189.
11. Evan AP, Worcester EM, Coe FL, et al. Mechanisms of
human kidney stone formation. Urolithiasis 2015;43(suppl
1:19–32.
12. Coe FL, Evan AP, Lingeman JE, Worcester EM. Plaque
and deposits in nine human stone diseases. Urol Res
2010;38:239–247.
13. Evan AP, Lingeman JE, Coe FL, et al. Randall’s plaque of
patients with nephrolithiasis begins in basement membranes
of thin loops of Henle. J Clin Invest 2003;111:607–616.
14. Evan AP, Coe FL, Gillen D, et al. Renal intratubular
crystals and hyaluronan staining occur in stone formers
with bypass surgery but not with idiopathic calcium oxalate
stones. Anat Rec (Hoboken), 2008;291:325–334.
15. Evan AP, Worcester EM, Williams JC Jr, et al. Biopsy
proven medullary sponge kidney: Clinical findings, histo-
pathology, and role of osteogenesis in stone and plaque
formation. Anat Rec (Hoboken), 2015;298:865–877.
16. Cifuentes Delatte L, Minon-Cifuentes JL, Medina JA. Pa-
pillary stones: Calcified renal tubules in Randall’s plaques.
J Urol 1985;133:490–494.
17. Evan A, Lingeman J, Coe F, Worcester E. Randall’s pla-
que: Pathogenesis and role in calcium oxalate ne-
phrolithiasis. Kidney Int 2006;69:1313–1318.
18. Williams JC, Jr, Matlaga BR, Kim SC, et al. Calcium ox-
alate calculi found attached to the renal papilla: Preliminary
evidence for early mechanisms in stone formation. J En-
dourol 2006;20:885–890.
19. Kuo RL, Lingeman JE, Evan AP, et al. Urine calcium and
volume predict coverage of renal papilla by Randall’s
plaque. Kidney Int 2003;64:2150–2154.
20. Kim SC, Coe FL, Tinmouth WW, et al. Stone formation is
proportional to papillary surface coverage by Randall’s
plaque. J Urol 2005;173:117–119.
21. Linnes MP, Krambeck AE, Cornell L, et al. Phenotypic
characterization of kidney stone formers by endoscopic and
histological quantification of intrarenal calcification. Kid-
ney Int 2013;84:818–825.
Address correspondence to:
James E. Lingeman, MD, FACS
Indiana University School of Medicine
1801 North Senate Blvd., Suite 200
Indianapolis, IN 46202
E-mail: jlingeman@iuhealth.org
Abbreviation Used
PPLA ¼ plugging, pitting, loss of contour,
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